Summary
We have studied the effect of dosage time of oxprenolol (Trasicor®) on its pharmacokinetics and pharmacodynamics in six healthy volunteers. The drug effects measured were heart rate and systolic blood pressure during exercise. Oxprenolol was taken orally at 08.00 h, 14.00 h, 20.00 h, and 02.00 h in randomized order, with 1 week between successive doses.
There were differences in the pharmacokinetics of oxprenolol for the ratio between the apparent volume of distribution and systemic availability (P=0.04) and for elimination half-life (P=0.006). Both were lowest after administration at 14.00 h (163 (77) l and 1.2 (0.6) h; mean (SD)) and highest after administration at 02.00 h (229 (100) l, and 1.7 (0.6) h).
The systolic blood pressure during exercise before oxprenolol did not vary with dosage time, but heart rate during exercise before intake was lowest before dosage time 08.00 h and highest before dosage time 20.00 h (P=0.03).
The time-course of heart rate during exercise after oxprenolol was described by a model that incorporated the factors drug concentration and spontaneous diurnal variation. EC50 and Emax did not vary between dosage times. The spontaneous diurnal variation in heart rate during exercise was unaffected by oxprenolol, leading to an apparently greater effect of oxprenolol during the night than during the day.
Similar content being viewed by others
References
Zuming L, Limin S, Chang Leng H (1986) Circadian rhythms of the onset of cerebral hemorrhage in patients. J West China Univ Med Sci 17: 290–293
Imhof PR, Muller P, Fasnacht D (1986) Observations on the circadian distribution of anginal attacks in patients with chronic, stable angina pectoris. Schweiz Rundschau Med (Praxis) 75: 1500–1503
Muller JE, Stone PH, Turi ZG (1985) Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 313: 1315–1322
Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH (1987) Circadian variation in the frequency of sudden cardiac death. Circulation 75: 131–138
Rocco MB, Nabel EG, Selweyn AP (1987) Circadian rhythms and coronary artery disease. Am J Cardiol 59: 13c-17c
Millar Craig MW, Bishop CN, Raftery EB (1987) Circadian variation of blood pressure. Lancet I: 795–797
Mann S, Millar Craig MW, Melville DI, Balasubramanian V, Raftery BE (1979) Physical activity and the circadian rhythm of blood pressure. Clin Sci 57: 291–294
Richards AM, Nichols MG, Espiner EA (1986) Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin Exp Theory Pract A8: 153–166
Mann S, Millar Craig MW, Balasubramanian V, Raftery EB (1980) Propranolol LA and ambulatory blood pressure. Br J Clin Pharmacol 10: 443–447
Mann S, Millar Craig MW, Balasubramanian V, Raftery EB (1981) Once daily beta-adrenoceptor blockade in hypertension: an ambulatory assessment. Br J Clin Pharmacol 12: 223–228
Raftery EB (1983) The effects of beta-blocker therapy on diurnal variation of blood pressure. Eur Heart J 4: 61–64
Millar Craig MW, Mann S, Balasubramanian V, Altman DG, Raftery EB (1983) The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension. Eur J Clin Pharmacol 24: 713–721
Davies CTM, Sargeant AJ (1975) Circadian variation in physiological responses to exercise on a stationary bicycle ergometer. Br J Indust Med 32: 110–114
Cable NT, Reilly T (1987) Influence of circadian rhythms on arm exercise. J Hum Movement Stud 13: 13–27
Ilmarinen J, Rutenfranz J, Kylian H, Klinst F (1975) Study of the circadian variation of different circulatory and respiratory functions at submaximal and maximal ergometer work. Eur J Appl Physiol 34: 255–267
Koopmans R, Oosterhuis B, Karemaker JM, Wemer J, van Boxtel CJ (1988) Pharmacokinetic-pharmacodynamic modelling of oxprenolol in man using continuous non-invasive blood pressure monitoring. Eur J Clin Pharmacol 34: 395–400
Langner B, Lemmer B (1988) Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol 1988: 619–624
Jonkers RE, van Boxtel CJ, Oosterhuis B (1987) Beta-2-adrenoceptor mediated hypocalemia and its abolishment by oxprenolol. Clin Pharmacol Ther 42: 627–633
Brunner L, Imhof P, Jack D (1975) Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man. Eur J Clin Pharmacol 8: 3–9
Metzler CM, Elfring GL, McEven AJ (1974) A user's manual for NONLIN, and associated programs. Research biostatistics. Upjohn, Kalamazoo, MI
Gibaldi M, and Perrier D (1982) Pharmacokinetics. Dekker, New York
Dixon WJ (1983) BMDP statistical software. Univ of Cal Press, Berkeley
Lemmer B, Winkler H, Ohm T, Fink M (1985) Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 330: 42–49
Kornhauser DM, Wood AJJ, Vestal RE, Wilkinson GR, Branch RA, Shand DG (1978) Biological determinants of propranolol disposition in man. Clin Pharmacol Ther 23: 165–174
Melander A, McLean A (1983) Influence of food on presystemic clearance of drugs. Clin Pharmacokin 8: 286–296
Lemmer B, Nold G (1991) Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol 32: 627–29
Martin BJ, Bender PR, Chen H (1986) Stress hormonal response to exercise after sleeploss. Eur J Appl Physiol 55: 210–214
Bond V, Balkissoon B, Franks BD, Brwlow R, Caprarola M, Bartley D, Banks M (1986) Effects of sleep deprivation on performance during submaximal and maximal exercise. J Sports Med 26: 169–174
Hossmann V, Fitzgerald GA, Dollery CT (1980) Circadian rhythm of baroflex reactivity and adrenergic vascular response. Cardiovasc Res 14: 125–129
Panza JA, Epstein SE, Quyyumi AA (1991) Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 325: 986–90
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koopmans, R., Oosterhuis, B., Karemaker, J.M. et al. The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man. Eur J Clin Pharmacol 44, 171–176 (1993). https://doi.org/10.1007/BF00315476
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315476